Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis

The PyMOL Molecular Graphics System

Warren L. DeLano · Medical Entomology and Zoology · 2002 · 18.1K citations

Life Sciences, Biology, Computational Biology +11

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Medicine, Oncology, Pharmacology +17

Protein Structure Modeling with MODELLER

Narayanan Eswar, David Eramian, Ben Webb et al. · Methods in molecular biology · 2008 · 1.8K citations

Life Sciences, Biochemistry, Biophysics +7

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S. Finn, Judy Dering, Dylan Conklin et al. · Breast Cancer Research · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

Razelle Kurzrock, Steven I. Sherman, Douglas W. Ball et al. · Journal of Clinical Oncology · 2011 · 551 citations · Full text

Medicine, Oncology, Pharmacology +17